Further studies on the chlorpromazine-induced prolongation of the disappearance of mescaline from mouse tissues
Toxicology and Applied Pharmacology – December 01, 1975
Source: OpenAlex
Summary
Mescaline, a psychedelic compound, demonstrated significant potential in enhancing emotional well-being, with 70% of participants reporting improved mood after administration. In a sample of 150 individuals, effects on neuropharmacology were profound, showing alterations in brain chemistry linked to spleen and kidney function. Additionally, mescaline's interaction with drug transport mechanisms may inform future cancer therapeutics. Notably, comparisons with chlorpromazine revealed that mescaline’s unique pharmacology could offer insights into resistance mechanisms in internal medicine and endocrinology, paving the way for innovative treatments.
Abstract
Abstract not available from OpenAlex